These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 26723018)
1. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda. Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018 [TBL] [Abstract][Full Text] [Related]
2. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon. Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266 [TBL] [Abstract][Full Text] [Related]
3. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study. Kan W; Teng T; Liang S; Ma Y; Tang H; Zuohela T; Sun G; He C; Wall KM; Marconi VC; Liao L; Leng X; Liu P; Ruan Y; Xing H; Shao Y BMJ Open; 2017 Sep; 7(9):e016012. PubMed ID: 28882911 [TBL] [Abstract][Full Text] [Related]
4. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]. Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780 [TBL] [Abstract][Full Text] [Related]
5. Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy. Sigaloff KC; Kayiwa J; Musiime V; Calis JC; Kaudha E; Mukuye A; Matama C; Nankya I; Nakatudde L; Dekker JT; Hamers RL; Mugyenyi P; Rinke De Wit TF; Kityo C AIDS Res Hum Retroviruses; 2013 Jun; 29(6):925-30. PubMed ID: 23517497 [TBL] [Abstract][Full Text] [Related]
6. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas. Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295 [TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children. Musiime V; Kaudha E; Kayiwa J; Mirembe G; Odera M; Kizito H; Nankya I; Ssali F; Kityo C; Colebunders R; Mugyenyi P AIDS Res Hum Retroviruses; 2013 Mar; 29(3):449-55. PubMed ID: 23308370 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13. Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373 [TBL] [Abstract][Full Text] [Related]
9. Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis. Jordan MR; Penazzato M; Cournil A; Vubil A; Jani I; Hunt G; Carmona S; Maphalala G; Mthethwa N; Watera C; Kaleebu P; Musanhu CC; Mtapuri-Zinyowera S; Dzangare J; Peeters M; Yang C; Parkin N; Bertagnolio S Clin Infect Dis; 2017 Nov; 65(12):2018-2025. PubMed ID: 29020335 [TBL] [Abstract][Full Text] [Related]
10. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children. Boerma RS; Boender TS; Sigaloff KC; Rinke de Wit TF; van Hensbroek MB; Ndembi N; Adeyemo T; Temiye EO; Osibogun A; Ondoa P; Calis JC; Akanmu AS J Int AIDS Soc; 2016; 19(1):21140. PubMed ID: 27836020 [TBL] [Abstract][Full Text] [Related]
11. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines. Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571 [TBL] [Abstract][Full Text] [Related]
12. Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia. Budayanti NS; Merati TP; Bela B; Mahardika GN Curr HIV Res; 2018; 16(5):374-382. PubMed ID: 30714528 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia. Getaneh Y; He Q; Rashid A; Kassa D; Kang L; Yi F; Liao L; Shao Y J Glob Antimicrob Resist; 2022 Sep; 30():418-427. PubMed ID: 35917929 [TBL] [Abstract][Full Text] [Related]
14. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF; Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367 [TBL] [Abstract][Full Text] [Related]
15. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis. de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries. Crowell TA; Danboise B; Parikh A; Esber A; Dear N; Coakley P; Kasembeli A; Maswai J; Khamadi S; Bahemana E; Iroezindu M; Kiweewa F; Owuoth J; Freeman J; Jagodzinski LL; Malia JA; Eller LA; Tovanabutra S; Peel SA; Ake JA; Polyak CS; Clin Infect Dis; 2021 Oct; 73(7):e2311-e2322. PubMed ID: 32785695 [TBL] [Abstract][Full Text] [Related]
17. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016. Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167 [TBL] [Abstract][Full Text] [Related]
18. Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda. Kaleebu P; Kirungi W; Watera C; Asio J; Lyagoba F; Lutalo T; Kapaata AA; Nanyonga F; Parry CM; Magambo B; Nazziwa J; Nannyonjo M; Hughes P; Hladik W; Ruberantwari A; Namuwenge N; Musinguzi J; Downing R; Katongole-Mbidde E; PLoS One; 2015; 10(12):e0145536. PubMed ID: 26700639 [TBL] [Abstract][Full Text] [Related]
19. Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis. Boerma RS; Sigaloff KC; Akanmu AS; Inzaule S; Boele van Hensbroek M; Rinke de Wit TF; Calis JC J Antimicrob Chemother; 2017 Feb; 72(2):365-371. PubMed ID: 27999070 [TBL] [Abstract][Full Text] [Related]
20. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa. Parboosing R; Naidoo A; Gordon M; Taylor M; Vella V J Med Virol; 2011 Sep; 83(9):1508-13. PubMed ID: 21739439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]